Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says
Lead A large observational study published on 18 March 2026 in BMJ Medicine by Washington University School of Medicine reports that interruptions in GLP‑1 therapy are linked to higher rates of heart attack, stroke and all‑cause death among adults with Type 2 diabetes. Researchers tracked electronic health records for more than 333,000 people with diabetes … Read more